FDLI
This article was originally published in The Tan Sheet
Executive Summary
Incoming Energy & Commerce Committee Chairman Tom Bliley (R- Va.) will speak at the first plenary session of the Food & Drug Law Institute annual meeting in Washington, D.C. on Dec. 13. Also appearing during that session will be FDA Commissioner David Kessler
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning